Efficacy Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Patients

NCT00615264 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

457

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 1 Diabetes

Interventions

DRUG: DiaPep277
DRUG: Placebo

Sponsor

Andromeda Biotech Ltd.